Masahiro Yamazaki Selected Research

Fatty Acids (Saturated Fatty Acids)

1/2023	Oral Exposure to Polystyrene Microplastics of Mice on a Normal or High-Fat Diet and Intestinal and Metabolic Outcomes.
12/2022	Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity.
1/2022	Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice.
1/2021	Low circulating arachidonic acid is associated with macroalbuminuria in diabetic patients: a cross-sectional examination of the KAMOGAWA-DM cohort study.
1/2021	ILC2s Improve Glucose Metabolism Through the Control of Saturated Fatty Acid Absorption Within Visceral Fat.
1/2021	Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Yamazaki Research Topics

Disease

52	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2004
15	Meniere Disease (Menieres Disease) 01/2014 - 01/2010
12	Endolymphatic Hydrops 01/2014 - 01/2010
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2007
9	Diabetic Nephropathies (Diabetic Nephropathy) 11/2019 - 11/2009
8	Sarcopenia 10/2023 - 05/2018
8	Diabetes Mellitus 10/2023 - 06/2014
8	Obesity 12/2022 - 01/2004
7	Neoplasms (Cancer) 04/2024 - 09/2016
7	Inflammation (Inflammations) 01/2023 - 03/2010
7	Body Weight (Weight, Body) 01/2022 - 05/2002
7	Albuminuria 01/2016 - 09/2007
6	Hypertension (High Blood Pressure) 01/2021 - 06/2014
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 03/2010
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2023 - 01/2021
5	COVID-19 01/2023 - 01/2021
5	Hyperglycemia 09/2022 - 03/2010
5	Atherosclerosis 01/2022 - 06/2010
4	Glucose Intolerance 05/2021 - 03/2012
4	Renal Cell Carcinoma (Grawitz Tumor) 08/2020 - 09/2016
3	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 05/2021
3	Hypoglycemia (Reactive Hypoglycemia) 08/2023 - 01/2021
3	Non-alcoholic Fatty Liver Disease 01/2023 - 10/2016
3	Muscular Atrophy (Muscle Atrophy) 12/2022 - 01/2021
3	Dyslipidemias (Dyslipidemia) 05/2021 - 06/2014
3	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2021 - 08/2003
3	Chronic Renal Insufficiency 01/2018 - 06/2014
3	Insulin Resistance 05/2015 - 01/2004
2	Hemorrhage 01/2024 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 07/2012
2	Ketosis 12/2023 - 09/2022
2	Dysbiosis 12/2022 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2022 - 01/2021
2	Constipation 03/2022 - 11/2020
2	Diarrhea 03/2022 - 11/2020
2	Atrophy 01/2022 - 01/2013
2	False Aneurysm (Pseudoaneurysm) 09/2021 - 01/2020
2	Fatty Liver 01/2021 - 01/2021
2	Margins of Excision 12/2020 - 04/2020
2	Heart Failure 04/2019 - 03/2013
2	Abdominal Obesity 01/2016 - 11/2015
2	Hypertriglyceridemia 01/2016 - 11/2015
2	Atrophic Gastritis 07/2012 - 04/2012
2	Overnutrition 04/2012 - 03/2010

Drug/Important Bio-Agent (IBA)

15	Hemoglobins (Hemoglobin)IBA 01/2022 - 06/2010
15	AlbuminsIBA 12/2019 - 11/2009
14	CreatinineIBA 01/2022 - 12/2012
12	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2012
8	Insulin (Novolin)FDA Link 01/2024 - 03/2011
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2012
8	GadoliniumIBA 01/2014 - 01/2010
8	gadodiamide (Omniscan)FDA Link 03/2013 - 10/2011
7	LipidsIBA 01/2023 - 09/2007
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2021
6	Blood Glucose (Blood Sugar)IBA 01/2023 - 03/2010
6	Uric Acid (Urate)IBA 05/2015 - 04/2012
5	AcidsIBA 08/2022 - 01/2012
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 04/2012
4	Dietary Fiber FDA Link 03/2024 - 01/2022
4	dapagliflozinIBA 10/2023 - 01/2021
4	Metformin (Glucophage)FDA LinkGeneric 03/2022 - 05/2016
4	SaltsIBA 08/2021 - 12/2012
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 03/2013
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 10/2016
3	AndrogensIBA 01/2021 - 09/2007
3	Axitinib (AG 013736)IBA 08/2020 - 09/2016
3	Indicators and Reagents (Reagents)IBA 11/2019 - 09/2014
3	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2019 - 03/2013
3	Dietary ProteinsIBA 01/2019 - 07/2015
3	HDL CholesterolIBA 01/2016 - 04/2015
3	Contrast MediaIBA 05/2013 - 01/2010
3	Pepsinogen A (Pepsinogen)IBA 01/2013 - 04/2012
3	gadoteridol (Prohance)FDA Link 10/2012 - 05/2011
2	Propolis (Bee Bread)IBA 12/2022 - 05/2015
2	Cystatin CIBA 01/2022 - 05/2018
2	Serum AlbuminIBA 10/2021 - 03/2010
2	Ointments (Pastes)IBA 04/2021 - 12/2020
2	SodiumIBA 01/2021 - 01/2018
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 11/2009
2	CholesterolIBA 12/2019 - 11/2019
2	Antihypertensive Agents (Antihypertensives)IBA 11/2019 - 12/2012
2	CarbohydratesIBA 01/2018 - 07/2015
2	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 03/2013
2	Dietary Plant Proteins (Vegetable Protein)IBA 01/2017 - 07/2015
2	gluconolactonaseIBA 01/2015 - 03/2012
2	Gadolinium DTPA (Magnevist)FDA Link 01/2013 - 01/2011
2	Hemoglobin AIBA 12/2012 - 09/2007
2	Testosterone (Sustanon)FDA Link 09/2007 - 09/2007

Therapy/Procedure

11	Glycemic Control 01/2024 - 09/2007
7	Intravenous Injections 01/2014 - 01/2010
5	Nephrectomy 04/2024 - 09/2016
5	Intravenous Administration 03/2013 - 01/2011
3	Brachytherapy 02/2024 - 05/2021
3	Therapeutics 09/2022 - 09/2015
3	Warm Ischemia 09/2021 - 04/2020
2	Radiotherapy 03/2024 - 06/2023
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2023 - 05/2021
2	Toothbrushing 04/2023 - 11/2021
2	Drug Tapering 09/2022 - 01/2021
2	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 08/2016 - 07/2015